Back to
UBS Group AG
SGMT12 quarters
Position history for
UBS Group AG's holdings in SAGIMET BIOSCIENCES INC
Yes. Ubs holds 339,930 shares of SGMT (Sagimet Biosciences), worth $2.6M, as of its Q2 2026 13F filing. It increased the position by 45,996 shares (+15.7%) from Q1 2026. Ubs has held SGMT in every 13F on record since Q3 2023, 12 quarterly filings.
Current Value
$2.6M
Current Shares
339,930
Total Value Change
+$2.6M
Total Shares Change
+336,939
Quarter-by-Quarter History
Other major holders of SGMT: BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P., FMR LLC, Woodline Partners LP, VANGUARD CAPITAL MANAGEMENT LLC